Universal GxP Compliance Platform

Every GxP Domain. One Platform. Human-Verified.

AI-powered quality and compliance for manufacturing, clinical, pharmacovigilance, laboratory, and distribution teams. Every AI recommendation passes through a human decision gate. Every action audit-trailed.

Verixa is the platform. Navira QA is the quality services team. Humans own the judgment.
Dashboard
Deviations
CAPAs
MIRA AI
Documents
Intelligence
GxP Context: GMP
12
Open Deviations
94%
CAPA On-Time
Low
Risk Score
ID SEVERITY STATUS
DEV-2024-001 Critical In Review
DEV-2024-002 High CAPA Active
DEV-2024-003 Medium Closed
Designed for 21 CFR Part 11
GMP · GCP · GVP · GLP · GDP
Self-Hosted · Your Cloud · Your Data
HITL Governance

Every Compliance Gap Carries a Cost

Time

Manual processes drain your team.

  • Deviation workarounds consuming 10-15 hours/week
  • CAPA tracking across spreadsheets and email
  • Audit preparation requiring full document recreation

Money

Unpredictable consulting spend.

  • Emergency audit prep engagements
  • Ad-hoc regulatory assessments
  • Repeat investigations of the same gaps

Risk

Findings that don't hold up under inspection.

  • Gaps discovered only during FDA audits
  • Inconsistent root cause analysis methodology
  • Non-auditable correction records

One Platform. Every GxP Domain.

Universal GxP Core with domain-specific activation.

Deviation Management

Severity classification, root cause, and closure workflows

CAPA Management

Corrective/preventive action tracking with effectiveness checks

Risk Assessment

5×5 RPN scoring and risk prioritization

Root Cause Analysis

6 methods + AI-assisted hypothesis generation

Document Control

4-tier library with version control and regulatory traceability

Training Management

Role-based learning paths and competency tracking

Audit Trail

Hash-chain protected, 15+ fields, immutable

Workflow Engine

SLA enforcement and escalation rules

Dashboards & Reporting

Real-time KPIs and regulatory-grade export

GxP Context Selector

One click activates domain-specific fields, workflows, roles, and AI context. Switch from GMP to GCP in seconds.

Intelligence That Assists. Humans That Decide.

Four core AI capabilities, each with a human decision gate.

Copilot

Natural language queries with contextual assistance. Ask questions about deviations, CAPAs, and compliance — get instant answers with audit trail.

AI Quality Scoring

Automated quality assessment for deviations and investigations. Passes through human QA gate before finalization.

Regulatory Q&A

RAG-based retrieval of your regulatory documents, SOPs, and prior FDA responses. Citations always transparent.

Compliance Intelligence

Analytics, training gap detection, and trend forecasting. AI identifies patterns; humans decide actions.

Every AI Output. Human-Approved.

HITL governance is non-negotiable for FDA and EMA.

1

AI Suggests

System generates recommendation

2

Human Reviews

SME validates and decides

3

Decision Logged

Action finalized by human

4

Audit Trail

Both AI and human logged

Deviation Classification

AI classifies deviation severity → QA Manager reviews and confirms

CAPA Recommendation

MIRA recommends corrective action → Quality Lead approves or modifies

Risk Scoring

Risk score calculated by RPN → Human acknowledges and adjusts

Anomaly Detection

Anomaly flagged in data → Investigator confirms or dismisses

From Molecule to Market to Post-Market

Universal platform with domain-specific depth.

GMP

Good Manufacturing Practice
  • Batch record deviations
  • Change control
  • Supplier audits
  • Environmental monitoring

GCP

Good Clinical Practice
  • Protocol deviations
  • Serious adverse events
  • Informed consent tracking
  • Audit readiness

GVP

Good Vigilance Practice
  • Adverse event reporting
  • Signal detection
  • Risk-benefit assessment
  • Regulatory submissions

GLP

Good Laboratory Practice
  • Study protocol compliance
  • Data integrity
  • Laboratory audits
  • Quality assurance records

GDP

Good Distribution Practice
  • Supplier qualification
  • Temperature monitoring
  • Batch tracking
  • Recall management

Cross-Domain Intelligence

When an inspector asks "show me all deviations across your organization" — it's one query across GMP, GCP, GVP, GLP, and GDP. One audit trail. One source of truth.

Built for Global Inspection Confidence

21 CFR Part 11

Electronic records and signatures for FDA compliance

EU GMP Annex 11

Computer systems validation and data integrity

ICH Q10

Pharmaceutical quality systems framework

GAMP 5

Guidance for validation of computerized systems

ICH E6(R3)

Good Clinical Practice for trials

EU GVP

Good Pharmacovigilance Practice

Your Cloud. Your Data. Your Control.

  • Self-Hosted

    Deploy on your AWS, Azure, or GCP account. You own the infrastructure.

  • Direct LLM Access

    You provide and pay for your own OpenAI, Anthropic, or Cohere API keys. Zero data sharing.

  • Data Sovereignty

    No Verixa cloud. No data escrow. Your data stays in your infrastructure.

  • Enterprise Security

    JWT authentication, 2FA, IP whitelisting, hash-chain integrity verification.

☁️

Cloud Agnostic

AWS, Azure, or GCP — your choice, your contract.

🔐

Encrypted at Rest

All data encrypted with keys you manage.

🔗

Hash-Chain Audit Trail

Immutable record of every change and approval.

📊

No Lock-In

Export your data in standard formats anytime.

You Buy Verixa. Navira QA Ensures Your Success.

Navira QA is our quality services team — GxP professionals who deploy, validate, and support every Verixa implementation in regulated environments. From Day 1 installation through post-deployment oversight, we own your success.

Implementation Services

Deployment & Configuration

Deploy Verixa on your AWS/Azure/GCP account. Configure domain-specific workflows, roles, and integrations. Handoff-ready in 2-3 weeks.

Validation (IQ/OQ/PQ)

GAMP 5-compliant installation, operational, and performance validation. Full CSV documentation package included.

Training

Role-based, scenario-driven training for QA, operations, regulatory, and compliance teams. Train-the-trainer model available.

Managed QMS Oversight

Navira QA runs alongside your team during the maturity period. As proficiency grows, we transition to advisory-only support.

Standalone Service Packs

Even if you don't use Verixa, these GxP services are available to all organizations.

GxP Compliance Audit

$4,500–$6,000
7–10 business days

Independent GxP audit for QA teams that need qualified bandwidth. Any domain. 7-10 business days.

Deliverables:

  • • Severity-classified findings report
  • • CAPA gap rubric with priorities
  • • Board-ready executive summary
  • • Hash-chain audit trail evidence
Cost Advantage: $4,500–$6,000 fixed vs. $13,000+ at standard rates. 55–65% savings.

Inspection Readiness Sprint

$15,000–$25,000
30 days

30-day intensive pre-inspection gap assessment, remediation, and evidence packaging for FDA, EMA, or MHRA.

Deliverables:

  • • Compliance readiness heatmap
  • • Prioritized remediation plan
  • • Inspector-ready evidence packs
  • • Mock inspection scenario
Risk Callout: A 483 is public. A warning letter freezes revenue 6–12 months. Consent decree: $5M–$50M+.

CAPA & Root Cause Fix

$12,000–$18,000
15–20 business days

Structured CAPA resolution — clears QA's backlog and fixes root cause. Breaks the cycle. 15-20 business days.

Deliverables:

  • • RCA methodology upgrade (5-Why, Fishbone, Fault Tree)
  • • CAPA rewrite with evidence linkage
  • • Inspection defensibility assessment
  • • Deviation trending report
Risk Callout: Each repeat deviation costs $15k–$40k. 3+ in same system signals broken CAPA process.

Navira QA Engagement Process

1

Scope & Tier

Fixed SOW locked Day 1

2

Evidence Intake

Structured via Verixa platform

3

Execution

AI-assisted with SME validation

4

QA Gate

Hash-chain verification

5

Delivery

7–10 days

30+ Verified QA Professionals. Every GxP Domain.

Navira QA maintains an on-demand network of qualified GxP professionals. Every audit finding, CAPA recommendation, and readiness assessment is reviewed and signed off by a domain expert.

GMP

Manufacturing QA
Data Integrity
Process Validation

GCP

Clinical Operations
TMF Management
BIMO Compliance

GVP

Pharmacovigilance
Signal Detection
ICSR Processing

GLP

Laboratory Studies
Computerized Systems
Data Validation

GDP

Distribution & Supply
Cold Chain
Serialization

Built for Every Role Protecting Compliance

VP Quality / Head of QA

Executive Owner

"Your next inspection is coming. Your current system isn't ready. Verixa gives you visibility, speed, and proof."

CFO / Finance

Cost & Risk

"Quality failures cost 10–100x the prevention. A single FDA warning letter: $5M–$50M. Verixa costs a fraction."

CRO/CDMO Quality Lead

Sponsor Confidence

"Every sponsor audit is a contract renewal test. Verixa proves you're audit-ready. Every time."

Board / Investors

Risk Mitigation

"A consent decree costs $5M–$50M+ and destroys shareholder value. Verixa is insurance that works."

How Verixa Compares

Capability Verixa Veeva Vault TrackWise Qualio
Cloud-Native Architecture
Modern, Responsive UI
21 CFR Part 11 E-Signatures
Multi-Domain GxP (5+ domains)
GxP Context Switching
AI-Assisted Quality (HITL)
Hash-Chain Audit Trail
Self-Hosted / Customer Cloud
Composable Pricing (by domain)

What We Don't Claim (Yet)

Agentic Panel System

Multi-agent AI deliberation for quality decisions is in our specification roadmap. Until it ships, we won't put it on the website.

Predictive Deviation Engine

Signal detection and trend forecasting are planned capabilities. We'll claim them when they're production-ready.

Unvalidated Efficiency Claims

We don't publish ROI statistics without customer data to support them. When our first customers share results, we'll publish them with permission.

Every claim on this website maps to a shipping capability. If it's not here, it's not built yet.

Common Questions About Verixa

What is Verixa?

+

Verixa is an AI-powered GxP quality and compliance platform for pharmaceutical and life sciences organizations. It covers all major GxP domains (GMP, GCP, GVP, GLP, GDP) through a universal core with domain-specific packs. Every AI recommendation passes through a human-in-the-loop decision gate with 21 CFR Part 11 compliant audit trails.

How does Verixa handle AI governance?

+

Verixa enforces Human-in-the-Loop (HITL) governance for every AI output. AI classifies — humans confirm. AI recommends — humans approve. AI scores — humans acknowledge. AI flags — humans confirm or dismiss. Both the AI suggestion and the human decision are captured in an immutable, hash-chain audit trail. This is non-negotiable for FDA and EMA compliance.

Where is Verixa deployed?

+

Verixa is self-hosted on your organization's own cloud infrastructure (AWS, Azure, or GCP). Your data never leaves your environment. You pay your own LLM API provider directly. Full data sovereignty — designed for regulated environments where data residency is non-negotiable.

What GxP domains does Verixa cover?

+

Verixa covers seven GxP domains through its universal core plus domain packs: GMP (manufacturing), GCP (clinical operations), GVP (pharmacovigilance), GLP (laboratory), GDP (distribution), Biometrics (data management and biostatistics), and Medical Affairs. A GxP Context Selector activates domain-specific fields, workflows, roles, and AI context.

What is Navira QA?

+

Navira QA is Verixa's quality services team. They handle platform deployment, GAMP 5 validation (IQ/OQ/PQ), team training, and managed QMS oversight during the maturity period. Navira QA also offers standalone GxP compliance services: audits from $4,500, inspection readiness sprints, and CAPA resolution.

How much does Verixa cost?

+

Verixa uses composable pricing: Platform Base + GxP Domain Packs (pay only for the domains you operate in) + MIRA AI Tiers. A GMP-only manufacturer pays less than a multi-domain pharma company. Contact us for a customized quote.

Vimal Veereshwarayya, PhD, RAC

Founder & CEO

20+ years in clinical quality assurance across GCP, GLP, GMP, pharmacovigilance, and computerized systems validation. PhD in Biochemical Pharmacology. Regulatory Affairs Certified (RAC). Before founding Verixa, Vimal led quality assurance programs at Genentech (7 years), Myokardia/BMS, Arcellx, and Alumis — spanning Phase I through Phase III clinical trials, biologics manufacturing, and cell therapy quality systems. Published researcher with work in the Journal of Biological Chemistry and Circulation.

GCP GLP GMP PV CSV Phase I-III Biologics Cell Therapy

The Team Behind Verixa & Navira QA

Vijayalakshmi Janakiraman

Chief Technology Officer

Co-Founder. Previously Head of Engineering at Diana Health and CTO at Zita. MS from NIT Trichy. Leads all platform architecture and evidence chain design.

Janani Rangesh

Product Lead

Owns the Verixa product roadmap. Deep expertise in GxP workflows and regulatory intelligence. Directly engages with early customers.

Raja Swaminathan

Engineering Head

Leads platform engineering — evidence chain architecture, hash-chain audit trails, deployment automation. 12+ years in biotech infrastructure.

Remya Senthil

Compliance Head

Regulatory methodology across all GxP domains. 18+ years in pharma quality assurance and FDA/EMA inspections.

Susmitha

Software Engineering QA

Quality gate for every Verixa release. Ensures compliance testing and 21 CFR Part 11 validation at every build.

Hemarekha Venkatachalam

Operations

Delivery operations and engagement management. Ensures every Navira QA service engagement runs on time and exceeds scope.

Strategic Advisor

Kalyanaraman Gopalakrishnan — 29 years enterprise technology. Strategic Business Unit Head at Exavalu. Industry veteran guiding Verixa's go-to-market and platform strategy.

See Verixa in Action

Request a personalized demo or scope your Navira QA service engagement.

GxP Compliance Insights & Analysis

Regulatory intelligence for quality and compliance leaders.

GMP

EU GMP Annex 1 — Key Implementation Challenges for QA Teams

Top 5 FDA 483 Observations in Data Integrity (2024–2025)

CAPA Effectiveness: What Inspectors Actually Look For

GCP

ICH E6(R3) — Preparing for the Proportionate Approach to GCP

BIMO Inspection Focus Areas: TMF Completeness Trends

Decentralised Clinical Trials: Compliance Considerations

GVP

EU GVP Module IX Revision — Signal Management Updates

ICSR Processing Failures: Common Inspection Findings

AI in Signal Detection: Regulatory Expectations vs. Reality

GLP

OECD GLP Advisory Document on Computerised Systems

GLP Study Disqualification Trends: What Triggers Rejection

GCLP for Clinical Laboratories: Bridging the Standards Gap

GDP

DSCSA Final Enforcement: Serialisation Compliance Readiness

Temperature Excursion Findings: EU GDP Inspection Trends

Cold Chain Qualification for Cell & Gene Therapies

Get in Touch

Request a Demo

See Verixa in action. Our product team will walk you through the platform, answer your GxP questions, and show how HITL governance works in practice.

Scope a Service Engagement

Work with Navira QA for GxP compliance audits, inspection readiness, or end-to-end CAPA execution. Fixed SOW, transparent pricing.

Prefer Email?

contact@verixa.ai